Sun, Mar 26, 2017 | updated 05:01 AM IST

Taking Tamoxifen does not escalate risk of uterine cancer: Study

Updated: Oct 05, 2016 11:22 IST

Washington D.C. (USA), Oct. 5 (ANI): A recent study carried out by Loyola Medicine researchers shuns the commonly spread belief that breast cancer drug Tamoxifen could increase the risk of uterine cancer.

The study carried out by Drs. Kathy S. Albain and Ronald K. Potkul enrolled 296 eligible post-menopausal breast patients with a type of early-stage breast cancer called estrogens receptor-positive.

Patients were randomly assigned to take Tamoxifen alone or Tamoxifen plus the hormone progestin.

They were followed and assessed at years two and five.

Researchers predicted that taking progestin would decrease the risk of abnormalities that can develop into uterine cancer.

Such abnormalities occur in the endometrium (inner lining of the uterus).

At year two, the primary time point, researchers evaluated 89 women who took Tamoxifen alone and 80 women who took Tamoxifen plus progestin.

There were five endometrial abnormalities in the Tamoxifen-alone group and one abnormality in the Tamoxifen-plus-progestin group.

This difference was not statistically significant.

All abnormalities were benign.

Only one additional benign abnormality was found at five years. No cancers were detected at two years or five years.

Two years after treatment began, only 6 percent of the patients in the Tamoxifen-alone group, and 3.6 percent in both groups combined had benign endometrial abnormalities.

Based on previous studies, researchers had projected that 30 percent of the women in the Tamoxifen-alone group would show endometrial

abnormalities.

Corresponding author is Kathy S. Albain said the reason the abnormality rate was much lower than expected most likely was due to the study's screening requirements.

All women recruited for the study underwent uterine ultrasound exams before taking tamoxifen.

If the ultrasounds showed a thickening of the inner lining of the uterus greater than 5 mm, a biopsy was performed.

If the biopsy showed an endometrial abnormality, the woman was excluded from the study.

"For women who are concerned about taking tamoxifen to treat or prevent breast cancer, our study suggests that a normal ultrasound before treatment may provide additional reassurance," Albain added.

Tamoxifen is a highly effective drug that is used both to treat breast cancer and help prevent breast cancer in healthy women who are at high

risk of developing the disease.

The first author of the study Ronald K. Potkul said, "However, many women who would benefit from taking tamoxifen fail to do so because they fear getting endometrial cancer. Our study found that for women, who did not have endometrial abnormalities when they began taking Tamoxifen, there was a very low rate of developing pre-malignant conditions."

The median age of the women in the study was 59.5 years.

They underwent endometrial ultrasounds at the beginning of the study and after two years and five years.

After two years, 67 percent of the women in the tamoxifen-alone group had a thickening of the inner lining of the uterus greater than 5 mm, compared with 60 percent of the women in the tamoxifen-plus-progestin group.

This difference was not statistically significant.

All women, who had a thickness greater than 5 mm underwent subsequent biopsies.

The biopsies revealed five cases of endometrial abnormalities in the Tamoxifen group, four cases of proliferative endometrium (more cells

than normal lining the uterus) and one case of simple hyperplasia (non-malignant clumping of cells).

One woman in the Tamoxifen-plus progestin group had an abnormality (proliferative endometrium).

None of the abnormalities in either group developed into uterine cancer.

Although there were more endometrial abnormalities in the Tamoxifen-alone group, the difference was not large enough to be statistically significant.

It would require a follow-up trial with thousands of women to determine whether adding progestin to Tamoxifen truly reduces the risk of uterine cancer.

"These data could potentially reassure certain postmenopausal women who fear endometrial side effects of Tamoxifen, but would otherwise benefit from nstituting this important adjuvant breast cancer and breast cancer chemoprevention therapy. However, validation in a larger trial is needed first before changing practice in all asymptomatic postmenopausal women," researchers concluded.

The multi-center study was published in the Nature journal, Breast Cancer. (ANI)

New Delhi [India], Mar. 25 (ANI): The findings of the National Family Health Survey 2015-16 confirm what we all knew from clinical evidence - that hypertension has become a major health concern among the Indian population, with as many as 22% Indians hypertensive.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A prescription weight-loss medication can decrease the urge to use opiates such as oxycodone, according to a recent study.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has discovered a new gene that is associated with Tau accumulation, which is one of the defining features of Alzheimer disease (AD).

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): All it takes is the flip of a protein "switch" within the tiny wire-like capillaries of the brain to increase the blood flow that ensures optimal brain function.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): Scientists have found that stem cell therapy repairs damaged lungs - raising hopes of a cure for the crippling chronic obstructive pulmonary disease (COPD) and cystic fibrosis.

Full Story >>

New method can cut dental implant failure

Updated: Mar 25, 2017 09:34 IST

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has come up with a new method to reduce dental implant failure.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has come up with a fluorogenic probe that can detect the activity of multidrug-resistant pathogens in an assay system.

Full Story >>

Virus hydrophobicity can help purify vaccines

Updated: Mar 25, 2017 07:46 IST

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has found that hydrophobic proteins on virus surfaces can help purify vaccines.

Full Story >>

Washington D.C. [USA], Mar. 25 (ANI): A team of researchers has shed light on why survivors of childhood brain tumours may be prone to heart disease, stroke, type 2 diabetes and early death.

Full Story >>

New Delhi [India], Mar. 24 (ANI): Continuing its efforts to raise awareness on tuberculosis and its diagnosis, Division of Clinical Microbiology & Molecular Medicine Department of Laboratory Medicine, AIIMS, and BD (Becton Dickinson India) for the third consecutive year organized a symposium today on "challenges in diagnosis and eradication of tuberculosis".

Full Story >>

New Delhi [India], Mar. 24 (ANI): On the solemn occasion of World Tuberculosis (TB) Day, Members of Parliament, policymakers, TB patients, survivors, and citizens of the civil society gathered at India Gate on Thursday, March 23 to pay tribute to the nearly five lakh lives lost due to this disease last year.

Full Story >>

New Delhi [India], Mar. 24 (ANI): Emergence of multi drug resistant TB and complications aggravated by high rates of co-infection with HIV-AIDS has renewed the threat of TB epidemic in India. With widespread prevalence of the infection, children experience a serious risk of contracting Tuberculosis, especially if they are under-nourished.

Full Story >>

New Delhi [India], Mar. 24 (ANI): Tuberculosis can affect any age, caste or class and it is one of the top 10 causes of death across the globe, ranking above HIV and malaria.

Full Story >>

New Delhi [India], Mar. 24 (ANI): Tuberculosis is one of the top 10 causes of death across the globe, ranking above HIV and malaria. According to the World Health Organization (WHO), in 2015, there were 10.4 million new cases of TB worldwide.

Full Story >>

London [UK], Mar. 23 (ANI): Want happy families? Then delay your decision to start a family, as a study suggests, children born to older mother experience have fewer behavioural, social and emotional problems.

Full Story >>

Washington D.C. [USA], Mar. 23 (ANI): For women, stay fit and maintain a healthy weight, as a study finds a higher waist-to-hip ratios increases the risk of ovarian cancer risk by more than a fifth.

Full Story >>

Washington D.C. [USA], Mar. 23 (ANI): A study finds that people who are born blind have heightened sense of hearing, smell and touch, suggesting that their brain "rewires" itself in the absence of visual information to boost other senses.

Full Story >>

New Delhi [India], Mar. 23 (ANI): For those suffering with age-related (degenerative) arthritis of the knee, a stage comes when all the reasonable non-operative options stops working.

Full Story >>

Hepatitis drug can help cut Ebola death rate

Updated: Mar 22, 2017 09:30 IST

Washington D.C. [USA], Mar. 22 (ANI): A class of drugs used to treat hepatitis and some forms of multiple sclerosis has shown promise in treating Ebola.

Full Story >>

Weekend surgery 'not riskier'

Updated: Mar 22, 2017 09:20 IST

Washington D.C. [USA], Mar. 22 (ANI): Day of the week has no impact on the survival chances of people undergoing emergency surgery, a new research has found.

Full Story >>